Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kemia closes $33.5mm Series B round

Executive Summary

Kemia, a biotech active in the discovery and development of diverse oral small-molecule drug candidates, closed a $33.5mm Series B financing led by JP Morgan Partners. New investors were Novo AS and Hamilton Apex Technology. All Series A investors returned: Alta Partners, Forward Ventures, Texas Pacific Group, TPG Ventures, and Novartis BioVentures.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies